- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 39/215 - Coronaviridae, e.g. avian infectious bronchitis virus
Patent holdings for IPC class A61K 39/215
Total number of patents in this class: 2202
10-year publication summary
20
|
34
|
29
|
27
|
18
|
36
|
426
|
562
|
579
|
171
|
2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
The Regents of the University of California | 18943 |
38 |
Zoetis Services LLC | 1537 |
28 |
BioNTech SE | 482 |
25 |
The Wistar Institute of Anatomy and Biology | 387 |
18 |
Board of Regents, The University of Texas System | 5370 |
17 |
The Trustees of the University of Pennsylvania | 4122 |
17 |
Inovio Pharmaceuticals, Inc. | 308 |
17 |
Modernatx, Inc. | 1181 |
17 |
Institut Pasteur | 798 |
16 |
Novavax, Inc. | 167 |
16 |
Curevac SE | 235 |
16 |
Icahn School of Medicine at Mount Sinai | 859 |
15 |
Providence Therapeutics Holdings Inc. | 20 |
15 |
City of Hope | 943 |
14 |
Intervet Inc. | 848 |
14 |
Boehringer Ingelheim Vetmedica GmbH | 1290 |
13 |
Janssen Pharmaceuticals, Inc. | 399 |
13 |
Glaxosmithkline Biologicals S.A. | 1701 |
12 |
Dynavax Technologies Corporation | 114 |
12 |
EpiVax, Inc. | 79 |
12 |
Other owners | 1857 |